Explained simply and clearly in this short video
Common Adverse Reactions Table 1 shows common adverse reactions, not including hypoglycemia, associated with the use of MOUNJARO in the pool of placebo-controlled trials in adults
Efficacy and safety of co-agonism of GIP, GLP-1, and glucagon receptors by retatrutide in type 2 diabetes: a randomised, placebo-controlled, phase 2 trial
Verified Patient My clothes fit better, I have less pain in my joints, I get compliments from family and friends, I have more energy and a greater desire to do things, my confidence is sky-high, and I have no shame being with a group of people. Madden Verified Patient If someone has given up on losing weight, I would tell them to definitely use this program it will work
doi: 10.1007/112_2006_0702 24 RamosS
Your increased risk may be small, as its not reported as a Contradicting the aforementioned 2021 review, a separate review published in Another reducing your risk of ED